HDI 3000 ULTRASOUND SYSTEM WITH L12-5 SCANHEAD

FDA Premarket Approval P940005 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for design change from hdi 3000(r) ultrasound system with l10-5 scanhead to hdi 3000(r) ultrasound system with l12-5 scanhead for the indication of an adjunct o mammography and physical breast examination, to provide a high degree of physician confidence in differentiating benign from malignant or suspicious breast lesions. This device provides the physician with additional information to guide a biopsy decision. Utlity of this system has been demonstrated for lesions with an indeterminate level of suspicion (los 2-4) by conventional diagnostic modalities. Using the hdi system in the evaluation of solid mass characteristics can reduce the number of biopsies perofrmed on indeterminate lesions.

DeviceHDI 3000 ULTRASOUND SYSTEM WITH L12-5 SCANHEAD
Generic NameSystem, Imaging, Pulsed Doppler, Ultrasonic
ApplicantADVANCED TECHNOLOGY LABORATORIES, INC.
Date Received1997-05-30
Decision Date1998-07-21
PMAP940005
SupplementS002
Product CodeIYN 
Advisory CommitteeRadiology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address ADVANCED TECHNOLOGY LABORATORIES, INC. 22100 Bothell Everett Hwy. p.o. Box 3003 bothell, WA 98041-3003

Supplemental Filings

Supplement NumberDateSupplement Type
P940005Original Filing
S002 1997-05-30 Normal 180 Day Track
S001 1996-07-25 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.